These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37202895)

  • 21. Novel tribenzylaminobenzolsulphonylimine based on their pyrazine and pyridazines: Synthesis, characterization, antidiabetic, anticancer, anticholinergic, and molecular docking studies.
    Mamedova G; Mahmudova A; Mamedov S; Erden Y; Taslimi P; Tüzün B; Tas R; Farzaliyev V; Sujayev A; Alwasel SH; Gulçin İ
    Bioorg Chem; 2019 Dec; 93():103313. PubMed ID: 31586711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioactive sulfonyl hydrazones with alkyl derivative: Characterization, ADME properties, molecular docking studies and investigation of inhibition on choline esterase enzymes for the diagnosis of Alzheimer's disease.
    Bilen E; Özdemir Özmen Ü; Çete S; Alyar S; Yaşar A
    Chem Biol Interact; 2022 Jun; 360():109956. PubMed ID: 35452634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, crystal structure and biological evaluation of spectroscopic characterization of Ni(II) and Co(II) complexes with N-salicyloil-N'-maleoil-hydrazine as anticholinergic and antidiabetic agents.
    Gondolova G; Taslimi P; Medjidov A; Farzaliyev V; Sujayev A; Huseynova M; Şahin O; Yalçın B; Turkan F; Gulçin İ
    J Biochem Mol Toxicol; 2018 Sep; 32(9):e22197. PubMed ID: 30044035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Silico Analysis of Green Tea Polyphenols as Inhibitors of AChE and BChE Enzymes in Alzheimer's Disease Treatment.
    Ali B; Jamal QM; Shams S; Al-Wabel NA; Siddiqui MU; Alzohairy MA; Al Karaawi MA; Kesari KK; Mushtaq G; Kamal MA
    CNS Neurol Disord Drug Targets; 2016; 15(5):624-8. PubMed ID: 26996169
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Metiefeng NT; Tamfu AN; Fotsing Tagatsing M; Tabopda TK; Kucukaydin S; Noah Mbane M; de Theodore Atchade A; Talla E; Henoumont C; Laurent S; Anouar EH; Dinica RM
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375357
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthesis, characterization, inhibition effects, and molecular docking studies as acetylcholinesterase, α-glycosidase, and carbonic anhydrase inhibitors of novel benzenesulfonamides incorporating 1,3,5-triazine structural motifs.
    Lolak N; Akocak S; Türkeş C; Taslimi P; Işık M; Beydemir Ş; Gülçin İ; Durgun M
    Bioorg Chem; 2020 Jul; 100():103897. PubMed ID: 32413628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural Triterpenoids Isolated from Akebia trifoliata Stem Explants Exert a Hypoglycemic Effect via α-Glucosidase Inhibition and Glucose Uptake Stimulation in Insulin-Resistant HepG2 Cells.
    Bian G; Yang J; Elango J; Wu W; Bao B; Bao C
    Chem Biodivers; 2021 May; 18(5):e2001030. PubMed ID: 33779055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary metabolites of Helichrysum plicatum DC. subsp. plicatum flowers as strong carbonic anhydrase, cholinesterase and α-glycosidase inhibitors.
    Aydin T
    Z Naturforsch C J Biosci; 2020 May; 75(5-6):153-159. PubMed ID: 32383693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer's disease: Quinolotacrine hybrids.
    Sadafi Kohnehshahri M; Chehardoli G; Bahiraei M; Akbarzadeh T; Ranjbar A; Rastegari A; Najafi Z
    Mol Divers; 2022 Feb; 26(1):489-503. PubMed ID: 34491490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual inhibition of the α-glucosidase and butyrylcholinesterase studied by molecular field topology analysis.
    Jabeen F; Oliferenko PV; Oliferenko AA; Pillai GG; Ansari FL; Hall CD; Katritzky AR
    Eur J Med Chem; 2014 Jun; 80():228-42. PubMed ID: 24780600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring indole-based-thiadiazole derivatives as potent acetylcholinesterase and butyrylcholinesterase enzyme inhibitors.
    Taha M; Rahim F; Uddin N; Khan IU; Iqbal N; Anouar EH; Salahuddin M; Farooq RK; Gollapalli M; Khan KM; Zafar A
    Int J Biol Macromol; 2021 Oct; 188():1025-1036. PubMed ID: 34390751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tannic acid as a natural antioxidant compound: Discovery of a potent metabolic enzyme inhibitor for a new therapeutic approach in diabetes and Alzheimer's disease.
    Türkan F; Taslimi P; Saltan FZ
    J Biochem Mol Toxicol; 2019 Aug; 33(8):e22340. PubMed ID: 30974029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In silico and in vitro studies confirm Ondansetron as a novel acetylcholinesterase and butyrylcholinesterase inhibitor.
    Gholami A; Minai-Tehrani D; Eriksson LA
    Sci Rep; 2023 Jan; 13(1):643. PubMed ID: 36635365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
    Hameed A; Zehra ST; Shah SJ; Khan KM; Alharthy RD; Furtmann N; Bajorath J; Tahir MN; Iqbal J
    Chem Biol Drug Des; 2015 Nov; 86(5):1115-20. PubMed ID: 25951978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment.
    Makhaeva GF; Lushchekina SV; Kovaleva NV; Yu Astakhova T; Boltneva NP; Rudakova EV; Serebryakova OG; Proshin AN; Serkov IV; Trofimova TP; Tafeenko VA; Radchenko EV; Palyulin VA; Fisenko VP; Korábečný J; Soukup O; Richardson RJ
    Bioorg Chem; 2021 Jul; 112():104974. PubMed ID: 34029971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer's disease.
    Singh YP; Shankar G; Jahan S; Singh G; Kumar N; Barik A; Upadhyay P; Singh L; Kamble K; Singh GK; Tiwari S; Garg P; Gupta S; Modi G
    Bioorg Med Chem; 2021 Sep; 46():116385. PubMed ID: 34481338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation of Some Phenolic Compounds from Plantago subulata L. and Determination of Their Antidiabetic, Anticholinesterase, Antiepileptic and Antioxidant Activity.
    Özaslan MS; Sağlamtaş R; Demir Y; Genç Y; Saraçoğlu İ; Gülçin İ
    Chem Biodivers; 2022 Aug; 19(8):e202200280. PubMed ID: 35796520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In silico, theoretical biointerface analysis and in vitro kinetic analysis of amine compounds interaction with acetylcholinesterase and butyrylcholinesterase.
    Kandasamy S; Loganathan C; Sakayanathan P; Karthikeyan S; Stephen AD; Marimuthu DK; Ravichandran S; Sivalingam V; Thayumanavan P
    Int J Biol Macromol; 2021 Aug; 185():750-760. PubMed ID: 34216669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholinesterases, α-glycosidase, and carbonic anhydrase inhibition properties of 1H-pyrazolo[1,2-b]phthalazine-5,10-dione derivatives: Synthetic analogues for the treatment of Alzheimer's disease and diabetes mellitus.
    Taslimi P; Turhan K; Türkan F; Sedef Karaman H; Turgut Z; Gulcin İ
    Bioorg Chem; 2020 Apr; 97():103647. PubMed ID: 32078939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-Diabetic, Anti-Cholinesterase, and Anti-Inflammatory Potential of Plant Derived Extracts and Column Semi-Purified Fractions of
    Rauf A; Almasoud N; Ibrahim M; Alomar TS; Khalil AA; Khursheed T; Khan MU; Jan MS; Bhardwaj K; Iriti M; Sharma R
    Front Biosci (Landmark Ed); 2024 May; 29(5):183. PubMed ID: 38812295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.